Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.10 EUR
Change Today -0.008 / -7.41%
Volume 527.8K
As of 10:17 AM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

diagnostic & therapeutic (HYGEIA) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/18/14 - €0.30
52 Week Low
08/4/15 - €0.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

diagnostic & therapeutic (HYGEIA) Related Businessweek News

No Related Businessweek News Found

diagnostic & therapeutic (HYGEIA) Details

Diagnostic and Therapeutic Center of Athens Hygeia SA provides primary and secondary healthcare services in Greece and internationally. It offers diagnostic and medical treatment services. The company operates in two segments, Healthcare Sector and Commercial Sector. It operates gamma-KNIFE brain radio surgery, positron emission tomography, radiation oncology, intensive care, organ transplant, one-day surgery, interventional neuroradiology and cerebral aneurysm embolization, neurosurgical system, and one day treatment centers, as well as Da Vinci S, a robotic surgery system. As of December 31, 2014, the company owned 4 private hospitals in Greece and Albania with a total capacity of 1,261 licensed beds, 58 operating rooms, 34 delivery rooms, and 9 intensive care units. It is also involved in the import, trading, and supply of medical technology products; trading of pharmaceuticals and general medical supplies; operation of canteens and restaurants; and research, production, and trading of cosmetics, as well as offers supply, storage, and distribution services for various medical supplies and implants. The company was founded in 1970 and is based in Athens, Greece.

3,088 Employees
Last Reported Date: 06/2/15
Founded in 1970

diagnostic & therapeutic (HYGEIA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

diagnostic & therapeutic (HYGEIA) Key Developments

Diagnostic & Therapeutic Center of Athens Hygeia S.A. Reports Consolidated Earnings Results for the First Quarter of 2015

Diagnostic & Therapeutic Center of Athens Hygeia S.A. reported consolidated earnings results for the first quarter of 2015. Consolidated revenue for the first quarter of 2015 reached €56.67 million, down by 1.4%, as opposed to €57.48 million in first quarter of 2014. EBITDA increased by 2.4%, amounting to earnings of €6.7 million, compared to earnings of €6.5 million for the same period last year. LBT was €0.5 million against €1.2 million in first quarter of 2014. Loss after taxes from continuing operations was €0.4 million against €0.6 million for the same quarter in 2014. The consolidated results for first quarter of 2015 and 2014 have been negatively affected by the unilateral Greek government decisions for cutbacks when invoicing hospitalization fees and diagnostic tests for people insured with national insurer EOPYY (rebate and claw-back).

Diagnostic & Therapeutic Center of Athens Hygeia S.A. Auditor Raises 'Going Concern' Doubt

Diagnostic & Therapeutic Center of Athens Hygeia S.A. filed its Annual on Mar 30, 2015 for the period ending Dec 31, 2014. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Diagnostic & Therapeutic Center of Athens Hygeia S.A., Annual General Meeting, May 21, 2015

Diagnostic & Therapeutic Center of Athens Hygeia S.A., Annual General Meeting, May 21, 2015., at 17:00 E. Europe Standard Time. Location: Nikolaos Louros Conference Centre. Agenda: To approve the individual and consolidated financial statements for the 2014 fiscal year, and the respective reports of the Board of Directors (BoD) and the Chartered Accountants/Auditors; to discharge of BoD members and Chartered Accountants/Auditors from any liability with regard to the 2014 fiscal year activities; to appoint Chartered Accountants/Auditors for the 2015 fiscal year; to approve remunerations and contracts in accordance with Articles 23a and 24 of Codified Law 2190/1920; to approve replacement of BoD Members; to approve replacement of Auditing Committee Member; and to consider other issues/announcements.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HYGEIA:GA €0.10 EUR -0.008

HYGEIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HYGEIA.
View Industry Companies

Industry Analysis


Industry Average

Valuation HYGEIA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIAGNOSTIC & THERAPEUTIC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at